
CAS Name: (6a,11b,16a)-6-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
Additional Names: 6a-fluoro-16a-methylprednisolone; 16a-methyl-6a-fluoroprednisolone
Percent Composit...
Literature References: Prepn: Edwards et al., J. Am. Chem. Soc. 82, 2318 (1960). Toxicity study: E. I. Goldenthal, Toxicol. Appl. Pharmacol. 18, 185 (1971).
CAS Name: N,N'-Bis(hydroxymethyl)urea
Additional Names: N,N'-dihydroxymethylurea
Trademarks: Methural
Percent Composition: C 30.00%, H 6.71%, N 23.32%, O 39.96%
Literature References: Prepn: Einhorn, Hamburger, Ber. 41, 26 (1908); Walter, US 1863426 (1927); US 2436355 (1946 to du Pont).
CAS Name: N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide
Additional Names: 1-methyl-2',6'-pipecoloxylidide; dl-N-methylpipecolic acid 2,6-dimethylanilide; dl-N-methylhexahydropicolinic...
Literature References: Prepn: Ekenstam et al., Acta Chem. Scand. 11, 1183 (1957); US 2799679 (1957 to A. B. Bofors). Prepn of other salts: Rinderknecht, Helv. Chim. Acta 42, 1324 (1959); GB 826668 (1960 to Crookes Labs.). Resolution of isomers: Tullar, J. Med. Chem. 14, 891 (1971); Friberger, Aberg, Acta Pharm. Suec. 8, 361 (1971). Pharmacology: Helmy et al., J. Egypt. Med. Assoc. 50, 688 (1967). Metabolism: Reynolds, Br. J. Anaesth. 43, 33 (1971). Toxicity data: G. Aberg, Acta Pharmacol. Toxicol. 31, 273 (1972).
CAS Name: 2-Amino-1,7-dihydro-6H-purine-6-thione
Additional Names: 2-aminopurine-6-thiol
Trademarks: Lanvis (GSK); Tabloid (GSK)
Percent Composition: C 35.92%, H 3.01%, N 41.89%, S 19.18%
Literature References: Prepn: Elion, Hitchings, J. Am. Chem. Soc. 77, 1676 (1955); Hitchings, Elion, US 2697709; US 2800473; US 2884667; Hitchings et al., US 3019224; US 3132144 (1954, 1957, 1959, 1962, and 1964, all to Burroughs Welcome).
CAS Name: (16b)-21-Chloro-9-fluoro-17-hydroxy-16-methylpregna-1,4-diene-3,11,20-trione
Additional Names: 21-chloro-11-dehydrobetamethasone
Percent Composition: C 64.62%, H 6.41%, Cl 8.67%, F...
Literature References: Prepn: Elks et al., DE 1902340; eidem, US 3721687 (1969, l973, both to Glaxo). Activity: Munro, Wilson, Br. Med. J. 3, 626 (1975). Radioimmunoassay: W. A. Webb, R. V. Brooks, Acta Endocrinol. Suppl. 212, 203 (1977). Toxicology: J. Tamura et al., J. Toxicol. Sci. 5, 45, 177 (1980). Comparative clinical studies: A. Lassus, Curr. Med. Res. Opin. 6, 165 (1979); T. Fredriksson, K. Nordin, ibid. 322. Clinical evaluation of ophthalmic form: D. Lloyd-Jones et al., Br. J. Ophthalmol. 65, 641 (1981); L. A. Eilon, S. R. Walker, ibid. 644; K. R. Wilhelmus et al., ibid. 699.
CAS Name: 5-Hydroxymethyl-6-methyl-2,4(1H,3H)-pyrimidinedione
Additional Names: 5-hydroxymethyl-6-methyluracil; 5-hydroxymethyl-4-methyluracil; 4-methyl-5-hydroxymethyluracil
Percent Composi...
Literature References: Prepn: Endicott, Johnson, J. Am. Chem. Soc. 63, 2063 (1941).
CAS Name: 2-[2-(Dimethylamino)ethyl]-4-(phenylmethyl)-1(2H)-phthalazinone
Additional Names: 4-benzyl-2-[2-(dimethylamino)ethyl]-1(2H)-phthalazinone
Percent Composition: C 74.24%, H 6.89%, N ...
Literature References: Prepn: Engelbrecht et al., DE 1046625; eidem, US 3017411 (1958, 1962, both to VEB Deutsches Hydrierwerk Rodleben). Pharmacology: D. Lenke, Arzneim.-Forsch. 7, 678 (1957).
CAS Name: 10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-one O-[2-(dimethylamino)ethyl]oxime
Additional Names: 2-[[(10,11-dihydro-5H-dibenz[a,d]cyclohepten-5-ylidene)amino]oxy]-N,N-dimethylethylami...
Literature References: Prepn: Engelhard et al., DE 1198353 (1965); Schutz, Hoffmeister, DE 1225169; Schutz et al., US 3505321 (1966, 1970 both to Bayer); Wrigley, Leeming, GB 1045911 (1966 to Pfizer). Toxicity study: F. Hoffmeister et al., Arzneim.-Forsch. 19, 846 (1969). Series of articles on pharmacology, metabolism, clinical data: ibid. 458-467; 846-878.
CAS Name: N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine
Additional Names: 5-(3-methylaminopropyl)-5H-dibenzo[a,d]cycloheptene; 7-(3-methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene; amim...
Literature References: Prepn: Engelhardt, Christy, BE 617967 (1962 to Merck Co.), C.A. 59, 517f (1963); Tishler et al., US 3244748 and US 3271451 (both 1966 to Merck Co.); Engelhardt et al., J. Med. Chem. 11, 325 (1968). Metabolism in man, pig and dog: Sisenwine et al., J. Pharmacol. Exp. Ther. 175, 51 (1970). Use in treatment of sleep apnea: R. W. Clark et al., Neurology 29, 1287 (1979); L. G. Brownell et al., N. Engl. J. Med. 307, 1037 (1982).
CAS Name: 4-Amino-N-(5-bromo-4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide
Additional Names: N1-(5-bromo-4,6-dimethyl-2-pyrimidinyl)sulfanilamide; 5-bromo-4,6-dimethyl-2-sulfanilamidopyrimidine...
Literature References: Prepn: English et al., J. Am. Chem. Soc. 68, 453 (1946). Pharmacology: C. M. Stowe et al., Am. J. Vet. Res. 29, 345 (1958).
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
